unknown
Stage
About
VYNE Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies that address difficult therapeutic challenges, primarily through its InhiBET™ BET inhibitor platform.
Explore VYNE Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.